FDA Review Criteria Are Insufficient To Prompt CMS Coverage – Feigal, Tunis

Proposals allowing FDA's approval criteria to play a greater role in Medicare coverage determinations should account for the fact that many devices are cleared via 510(k) and not reviewed for clinical effectiveness, CDRH Director David Feigal asserted Oct. 11